Morgan Stanley Upgrades Novartis to Equal-Weight
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Vincent Meunier has upgraded Novartis (NYSE:NVS) from Underweight to Equal-Weight.
September 25, 2023 | 8:54 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novartis has been upgraded from Underweight to Equal-Weight by Morgan Stanley, which could positively impact the stock's performance.
The upgrade from Morgan Stanley indicates a more positive outlook for Novartis. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100